Author

I. T. S. Meliala

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

H. Zhao· 1 shared M. Miyagishi· 1 shared M. Wei· 1 shared R. Hosea· 1 shared S. Hillary· 1 shared S. Wu· 1 shared V. Kasim· 1 shared W. Duan· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

H. Zhao

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintOct 7, 2023

YY2/BUB3 axis-mediated SAC hyperactivity determines tumor cell fate through chromosomal instability

R. Hosea, W. Duan, I. T. S. Meliala…·V. Kasim

This study identifies the YY2/BUB3 axis as a regulator of SAC activity and shows how SAC hyperactivity and CIN levels influence tumor cell fate and drug sensitivity.

DOI 10.1101/2023.10.07.561167

humanDNA methylation

𝕏 PostBluesky